Abstract
Besides a cholesterol-lowering effect, simvastatin possesses anti-inflammatory properties attributed to inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and/or direct binding to, and inhibition of, the integrin lymphocyte function associated antigen-1 (LFA-1). We have shown that simvastatin protects against multiple low dose streptozotocin (MLDS) induced type 1 diabetes in mice. Presently, we examined if this effect could be abolished by co-administration of mevalonic acid, thus determining if the protective effect is dependent or independent of inhibition of HMG-CoA reductase. Mevalonic acid did not affect the protective effect of simvastatin against MLDS diabetes. Moreover, spleens from these mice did not show any signs of toxic side-effects, thus excluding the possibility that the protective effect is secondary to a general inflammatory response. We suggest that simvastatin's protective effect mainly is independent of HMG-CoA reductase inhibition. This implies that inhibition of LFA-1 activation is important for the protective effect exerted by simvastatin.
References
Mar 1, 1992·Diabetes·K C HeroldR Hirsch
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S G PaikS I Shin
Aug 1, 1995·Journal of the American College of Cardiology·H BuchwaldS E Williams
Mar 1, 1995·Diabetes·K C HeroldQ Sun
Oct 19, 1996·Lancet·C J VaughanB M Buckley
Jun 5, 1998·JAMA : the Journal of the American Medical Association·J R DownsA M Gotto
Nov 24, 1999·The Journal of Biological Chemistry·L LiuJ M Harlan
Mar 1, 2000·Biochemical and Biophysical Research Communications·S TakeuchiM Yokoyama
May 26, 2001·British Journal of Pharmacology·T J StalkerR Scalia
Oct 10, 2001·Journal of Neuroscience Research·R StanislausI Singh
Jan 17, 2002·European Heart Journal·J SimesJ Shepherd
Oct 9, 2002·Trends in Pharmacological Sciences·Gabriele Weitz-Schmidt
Nov 9, 2004·Atherosclerosis. Supplements·T R PedersenUNKNOWN Scandinavian Simvastatin Survival Study Group
Dec 14, 2004·Arthritis and Rheumatism·Gaby PalmerNathalie Busso
Jan 13, 2006·Kidney International·M ChristensenM P Madaio
Jul 20, 2007·The Journal of Pharmacology and Experimental Therapeutics·Tobias RydgrenStellan Sandler
Citations
Sep 29, 2011·World Journal of Diabetes·David J Hill
Jan 24, 2014·Advances in Pharmacological Sciences·F O OmoruyiA O Okorodudu
Oct 1, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Vinayagam RamachandranPoomalai Senthilraja
Aug 11, 2010·Chemico-biological Interactions·K KarthikesanV P Menon
Jan 13, 2011·The American Journal of Pathology·Arturo Bravo-NuevoLaura E Benjamin
Mar 13, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Kiessoun KonatéNicolas Barro
Jan 30, 2015·Cell Biochemistry and Biophysics·Shuang HaoKexiang Liu
Nov 1, 2012·European Journal of Pharmacology·Rajendran Naresh KumarPanchanatham Sachdanandam
Apr 12, 2020·Journal of Diabetes Investigation·Eiji KawasakiNobuhiko Koga
Apr 15, 2010·American Journal of Physiology. Endocrinology and Metabolism·K C MarchandD J Hill
Sep 23, 2014·European Journal of Pharmacology·Neelamegam Kandasamy, Natarajan Ashokkumar